Stoke Therapeutics Income Statement (2022-2025) | STOK

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 3.00M3.23M2.90M3.27M5.15M2.48M3.31M2.80M4.22M4.83M4.89M22.61M158.57M13.82M10.63M
Operating items
Research & Development 18.31M18.36M20.11M21.06M19.63M20.55M20.27M21.78M22.37M21.14M22.20M23.42M32.68M25.86M37.70M
Selling, General & Administrative 9.49M10.11M9.94M9.38M10.21M10.23M10.27M10.61M10.22M13.04M12.69M12.84M14.65M15.26M16.03M
Operating Expenses 27.80M28.47M30.05M30.44M29.84M30.78M30.54M32.39M32.59M34.17M34.90M36.27M47.33M41.12M53.72M
Operating Income -24.80M-25.24M-27.15M-27.18M-24.69M-33.26M-27.23M-29.59M-28.37M-29.34M-30.00M-13.65M111.24M-27.30M-43.09M
EBIT -24.80M-25.24M-27.15M-27.18M-24.69M-33.26M-27.23M-29.59M-28.37M-29.34M-30.00M-13.65M111.24M-27.30M-43.09M
Non-operating items
Interest & Investment Income 0.10M0.54M0.99M1.48M2.10M2.57M2.65M2.59M2.43M3.69M3.54M2.97M2.89M3.79M3.46M
Other Non Operating Income 0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M-0.43M-0.05M0.03M0.20M0.03M0.03M0.00M
Non Operating Income 0.15M0.59M1.04M1.52M2.15M2.61M2.69M2.63M2.00M3.65M3.57M3.17M2.92M3.82M3.47M
Net income details
EBT -24.69M-24.69M-26.15M-25.70M-22.59M-30.70M-24.58M-27.00M-26.37M-25.70M-26.43M-10.68M114.16M-23.48M-39.62M
Tax Provisions 1.28M-1.28M
Profit After Tax -24.65M-24.65M-26.11M-25.66M-22.55M-30.65M-24.54M-26.96M-26.37M-25.70M-26.43M-10.48M112.88M-23.48M-38.35M
Income from Continuing Operations -24.69M-24.69M-26.15M-25.70M-22.59M-30.70M-24.58M-27.00M-26.37M-25.70M-26.43M-10.68M112.88M-23.48M-38.35M
Consolidated Net Income -24.69M-24.69M-26.15M-25.70M-22.59M-30.70M-24.58M-27.00M-26.37M-25.70M-26.43M-10.68M112.88M-23.48M-38.35M
Income towards Parent Company -24.69M-24.69M-26.15M-25.70M-22.59M-30.70M-24.58M-27.00M-26.37M-25.70M-26.43M-10.68M112.88M-23.48M-38.35M
Net Income towards Common Stockholders -24.69M-24.69M-26.15M-25.70M-22.59M-30.70M-24.58M-27.00M-26.37M-25.70M-26.43M-10.68M112.88M-23.48M-38.35M
Additional items
EPS (Basic) -0.66-0.63-0.66-0.65-0.53-0.69-0.55-0.60-0.57-0.46-0.47-0.171.95-0.40-0.65
EPS (Weighted Average and Diluted) -0.66-0.63-0.66-0.65-0.53-0.69-0.55-0.60-0.57-0.46-0.47-0.171.90-0.40-0.65
Shares Outstanding (Weighted Average) 37.36M39.19M39.42M39.43M44.15M44.19M44.26M44.65M46.30M52.12M52.65M52.97M54.08M54.60M54.80M
Shares Outstanding (Diluted Average) 37.45M39.26M39.42M38.90M42.54M44.19M44.27M43.99M46.25M55.77M56.34M54.01M59.40M59.68M60.40M
EBITDA -25.16M-25.24M-26.54M-25.13M-21.97M-30.43M-24.31M-26.84M-26.35M-25.71M-26.25M-10.80M112.93M-23.28M-38.00M
Shares Outstanding 39.04M39.38M39.43M39.44M44.18M44.20M44.29M45.92M46.50M52.31M52.94M54.03M54.60M54.72M55.12M
Tax Rate 1.123.23